India has agreed to supply to Malaysia hydroxychloroquine for the treatment of COVID-19

The government of India agreed to sell Malaysia hydroxychloroquine – antimalarial drug with potential efficacy against COVID-19. Earlier, new Delhi has partially lifted a temporary ban on the export of the drug, writes Reuters.

India is the largest manufacturer of hydroxychloroquine, sales worldwide have soared due to reports of potential antimalarial drug in the fight against coronavirus infection. The increased demand for the drug has forced India last month to impose a ban on the export of hydroxychloroquine, this ban was partially lifted after persistent requests from the United States. Now the authorities have allowed the export of 89,1 thousand tablets in Malaysia. This drug will be used by Malaysian doctors in the therapy of patients with easy and moderate for COVID-19.

Meanwhile in France, said the dangerous side effects of anti-malarial drug: in the country there were 42 adverse events of the heart with the use of hydroxychloroquine. Medical regulators have warned about the importance of observing caution in the use of experimental treatment coronavirus infection.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]